HCA Healthcare, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -25

OP Asset Management Ltd Makes New Investment in HCA Healthcare, Inc. $HCA - MarketBeat

AI-generated analysis

πŸ“ˆ OP Asset Management Ltd opened a new position in HCA Healthcare by buying 27,224 shares worth approximately $12.9 million in Q1.

🏦 Institutional ownership remains heavy at 62.73%, with Nordea and Nomura increasing their holdings in the fourth quarter.

πŸ“‰ Analysts have become more cautious after HCA missed earnings estimates, leading multiple firms to cut price targets.

πŸ’° The company reported quarterly revenue of $19.11 billion, representing a 4.3% increase compared to the same quarter last year.

πŸ“… HCA Healthcare declared a quarterly dividend of $0.78 per share with an ex-dividend date of June 16th.

πŸ₯ TriStar, a division of HCA, received a certificate of need to build a freestanding emergency room in Lebanon.

πŸ‘” The company is experiencing leadership turnover as its chief clinical officer is set to exit after four years.

πŸ“Š The stock currently trades with a consensus price target of $503 and a 'Moderate Buy' rating from analysts.

Bullish Signals
  • OP Asset Management Ltd initiated a new position in HCA Healthcare, buying 27,224 shares valued at approximately $12.9 million.
  • Several other institutional investors increased their stakes, including Nordea Investment Management AB which grew its position by 11.2% and Nomura Asset Management Co. Ltd. which grew holdings by 6.2%.
  • HCA Healthcare reported quarterly revenue of $19.11 billion, which was up 4.3% compared to the same quarter last year.
  • The company received a certificate of need to build a freestanding emergency room in Lebanon, supporting continued facility expansion and local growth.
  • HCA Healthcare Foundation awarded $2.1 million in grants to 89 Middle Tennessee nonprofits, reinforcing community ties and brand goodwill.
Risk Factors
  • Multiple brokerages cut their price targets on HCA Healthcare following recent earnings that slightly missed analyst estimates.
  • Barclays reduced its price objective from $551.00 to $496.00 and set an 'overweight' rating, while Wells Fargo decreased its target from $481.00 to $436.00 with an 'equal weight' rating.
  • Sanford C. Bernstein significantly reduced its price objective from $503.00 to $413.00 and set a 'market perform' rating for the company.
  • The company's chief clinical officer is set to exit after four years, creating leadership turnover at the organization.
Full Analysis
OP Asset Management Ltd initiated a new position in HCA Healthcare, Inc. (NYSE: HCA) during the first quarter by purchasing 27,224 shares valued at approximately $12.9 million. This move adds to existing institutional interest, with other firms like Nordea and Nomura increasing their stakes in Q4, while overall institutional ownership remains high at 62.73%. Despite the new investment, Wall Street sentiment has turned cautious following a recent earnings miss where HCA reported $7.15 EPS against estimates of $7.19. Consequently, major brokerages including Barclays, Wells Fargo, and Sanford C. Bernstein have cut their price targets, resulting in a consensus rating of 'Moderate Buy' with an average target of $503. The company reported quarterly revenue of $19.11 billion, up 4.3% year-over-year, and declared a quarterly dividend of $0.78 per share payable on June 30th. While the firm is highlighted as a long-term value play due to demographic trends and recent facility expansions, it also faces leadership turnover with the departure of its chief clinical officer after four years.